Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.56
Delayed Data
As of 3:26pm ET
 +0.0005 / +0.02%
Today’s Change
1.93
Today|||52-Week Range
7.85
-19.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues2.4M0.000.000.00
 
 
Cost of Goods Sold530.5K0.000.000.00
 
 
Depreciation And Amortization312.9K7.9K7.0K3.0K
 
 
 
 
 
 
Operating ExpensesGross Income1.5M-7.9K-7.0K-3.0K
 
 
 
 
 
General Expenses3.8M2.0M2.0M1.7M
 
 
 
 
 
Research And Development113.3K274.1K577.8K444.4K
 
 
 
 
 
Total Operating Expenses4.6M2.0M2.0M1.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.2M-2.0M-2.0M-1.7M
 
 
 
 
 
Extraordinary Credit10.0K--0.000.00
 
 
Extraordinary Charge-1.7M---1.6M-850.7K
 
 
 
 
Interest Expense On Debt0.005.9K9.0K7.0K
 
 
 
 
Equity In Earnings-847.3K0.000.000.00
 
 
Other Expenses1.1M-99.6K-12.0K23.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.9M-2.1M-3.6M-2.6M
 
 
 
 
 
Minority Interest-1.2M0.000.000.00
 
 
Discontinued Operations0.00-402.2K0.000.00
 
 
Extraordinary Items0.000.00-688.7K0.00
 
 
Net Income-2.5M-2.5M-3.6M-2.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.2M2.3M2.6M2.7M
 
 
 
 
 
Shares To Calculate EPS Diluted2.2M2.3M2.6M2.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.10-$1.08-$1.70-$0.90
 
 
 
 
 
EPS Diluted-$1.10-$1.08-$1.40-$0.90